Doms № 5 -2022

Features of the course of acute coronary syndrome in patients with diabetes

Halushko O. A.

Shupik National Healthcare University of  Ukraine, Department of Family Medicine and Outpatient Care

Boliuk M. V.

Shupik National Healthcare University of  Ukraine, Department of Anesthesiology

and Intensive Therapy


Key words: diabetes mellitus; acute coronary syndrome; pain syndrome.


Acute coronary syndrome (ACS) remains a common cause of hospitalization for patients with diabetes mellitus (DM). Due to the frequent development of diabetic neuropathy, it is believed that this category of patients is characterized by a high frequency of atypical acute coronary syndrome, but data on this are quite contradictory. The objective. To determine the features of the clinical course and manifestations of pain syndrome in patients with ACS with accompanying diabetes.

Materials and methods. The study involved 36 patients with diabetes (22 men and 14 women) aged 44-86 years, hospitalized urgently for ACS. Pain syndrome was assessed at the time of hospitalization and immediately after coronary artery revascularization according to the following criteria: visual analog scale (VAS), Numerical Rating Scale (NRS), clinical data, and biochemical markers.

Results. The majority of patients (91.67%) at the time of hospitalization complained of chest pain, the rest were not bothered by any pain. During the survey, patients described pain as “burning” (30.56%), “squeezing” (30.56%), “squeezing” (25.0%), “tingling” (5.56%). There were also complaints of difficulty breathing (13.89%), shortness of breath (11.1%), palpitations (41.67%). The appearance of excessive sweating was noticed by 16.67% of patients. There was no statistically significant difference between the results of pain assessment by VAS and NRS (p> 0.1). The average value of glycemia at the time of hospitalization was 8.19 ± 3.45 mmol / l (men – 8.17 ± 3.61 mmol / l, women – 8.28 ± 3.13 mmol / l). Glycemia greater than 10.0 mmol / l was detected in 8 patients, which was 22.22% of all patients. This category of patients was dominated by patients with severe pain (62.5%). Conclusions. In patients with ACS and diabetes, the typical clinical picture of ACS prevailed (91.67% of patients) over the painless form. Prior to revascularization, moderate and severe pain occurred with equal frequency; there is no statistical difference between blood pressure, heart rate and glycemia (p> 0.1) in patients with severe and moderate pain. Hyperglycemia (≥10.0 mmol / l) was found in 22.22%, among this category of patients was dominated by patients with severe pain.


  1. IDF Diabetes Atlas 2021 – 10th edition. Access:
    Chen L, Islam RM, Wang J, Hird TR, Pavkov ME, et al. A systematic review of trends in all-cause mortality among people with diabetes. Diabetologia. 2020 Sep;63(9):1718- 1735. doi: 10.1007/s00125-020-05199-0. Epub 2020 Jul 6. PMID: 32632526.
  2. Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1. PMID: 31197153.
    Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmaco-therapy. Clin Ther. 2018 Jun;40(6):828-849. doi: 10.1016/j. clinthera.2018.04.001. Epub 2018 Apr 30. PMID: 29709457.
  3. Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021 Jul;17(7):400-420. doi: 10.1038/ s41574-021-00496-z. Epub 2021 May 28. PMID: 34050323.
    Ängerud KH, Thylén I, Sederholm Lawesson S, Eliasson M, Näslund U, Brulin C; SymTime Study Group. Symptoms and delay times during myocardial infarction in 694 patients with and without diabetes; an explorative cross-sectional study. BMC Cardiovasc Disord. 2016 May 26;16(1):108. doi: 10.1186/s12872-016-0282-7. PMID: 27386934; PMCID: PMC4937542.
    Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000 Jun 28;283(24):3223-9. doi: 10.1001/ jama.283.24.3223. PMID: 10866870.
  4. Berman N, Jones MM, De Coster DA. ‘Just like a normal pain’, what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals. BMJ Open. 2017 Sep 15;7(9):e015736. doi: 10.1136/bmjopen-2016-015736. PMID: 28918410; PM- CID: PMC5640147.
    Halushko O, Boliuk M. The risks and difficulties of diagnosing myocardial infarction in diabetic patients (review and own experience). Emergency medicine, 2020, 16(2): 37-41. doi:10.22141/2224-0586.16.2.2020.203139
  5. Johnson CAH, Pitta NC, Dessotte CAM, Dantas RAS, Rossi LA. Knowledge, attitudes, and beliefs about acute coronary syndrome among patients with type 2 diabetes. Rev Lat Am Enfermagem. 2021 Nov 19;29:e3503. doi: 10.1590/1518- 8345.5435.3503. PMID: 34816872; PMCID: PMC8616171.
    Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/ EIJY19M01_01. PMID: 30667361.
  6. Unifikovanyy klinichnyy protokol ekstrenoyi, pervynnoyi, vtorynnoyi (spetsializovanoyi), tretynnoyi (vysokospetsi- alizovanoyi) medychnoyi dopomohy ta kardioreabilitatsiyi «hostryy koronarnyy syndrom z elevatsiyeyu sehmenta ST». Approved by the Order of the Ministry of Health of Ukraine of September 14, 2021 No1936. Available at: https://zakon.
    Sung YT, Wu JS. The Visual Analogue Scale for Rating, Ranking and Paired-Comparison (VAS-RRP): A new tech- nique for psychological measurement. Behav Res Methods. 2018 Aug;50(4):1694-1715. doi: 10.3758/s13428-018-1041-8. PMID: 29667082; PMCID: PMC6096654.
  7. Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scand J Pain. 2016 Oct;13:67-75. doi: 10.1016/j.sjpain.2016.06.012. Epub 2016 Jul 27. PMID: 28850536.
    Shafshak TS, Elnemr R. The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain. J Clin Rheumatol. 2021 Oct 1;27(7):282-285. doi: 10.1097/RHU.0000000000001320. PMID: 31985722.
  8. Kim YS, Park JM, Moon YS, Han SH. Assessment of pain in the elderly: A literature review. Natl Med J India. 2017 Jul- Aug;30(4):203-207. doi: 10.4103/0970-258X.218673. PMID: 29162753.
    Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x. PMID: 16000093.
  9. . Fu R, Li S-D, Song C-X, Yang J-A, Xu H-Y, Gao X-J, et al. Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction-an analysis from China Acute Myocardial Infarction (CAMI) registry. J Geriatr Cardiol. May 2019;16(5):395-400. doi: 10.11909/j.issn.1671-5411.2019.05.002. PMID: 31217792; PMCID: PMC6558571.
  10. Arnold SV, Spertus JA, Lipska KJ, Tang F, Goyal A, McGuire DK, et al. Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study. Eur J Prev Cardiol. 2015 Jun;22(6):779-87. doi: 10.1177/2047487314533622. Epub 2014 Apr 16. PMID: 24740679; PMCID: PMC4199926.
  11. Read SH, Fischbacher CM, Colhoun HM, Gasevic D, Kerssens JJ, McAllister DA, et al. Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia. 2019 Mar;62(3):418-425. doi: 10.1007/s00125-018-4796-7. Epub 2019 Jan 17. PMID: 30656362; PMCID: PMC7019674.
  12. Draman MS, Thabit H, Kiernan TJ, O’Neill J, Sreenan S, McDermott JH. A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literature. En- docrinol Diabetes Metab Case Rep. 2013;2013:130058. doi: 10.1530/EDM-13-0058. Epub 2013 Oct 28. PMID: 24616778; PMCID: PMC3921998.
  13. Tracey I, Woolf CJ, Andrews NA. Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment. Neuron. 2019 Mar 6;101(5):783-800. doi: 10.1016/j.neuron.2019.02.019. PMID: 30844399; PMCID: PMC6800055.
  14. Cowen R, Stasiowska MK, Laycock H, Bantel C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015 Jul;70(7):828-47. doi: 10.1111/anae.13018. Epub 2015 Mar 14. PMID: 25772783.
  15. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-dia- betes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486. Erratum in: Eur Heart J. 2020 Dec 1;41(45):4317. PMID: 31497854.
  16. Hirsch IB, O’Brien KD. How to best manage glycemia and non-glycemia during the time of acute myocardial infarction. Diabetes Technol Ther. 2012 Jun;14 Suppl 1(Suppl 1):S22- 32. doi: 10.1089/dia.2012.0095. PMID: 22650221; PMCID: PMC3388496.